Anandamide Dysfunction in Prodromal and Established Psychosis

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|18|32|5188-5193

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.18, Iss.32, 2012-11, pp. : 5188-5193

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Stress and the Prodromal Phase of Psychosis

By  

Current Pharmaceutical Design, Vol. 18, Iss. 4, 2012-02 ,pp. : 527-533

Bentham Science Publishers

Access to resources Recommend Favorite

Philosophical Issues in the Prodromal Phase of Psychosis

By  

Current Pharmaceutical Design, Vol. 18, Iss. 4, 2012-02 ,pp. : 596-605

Bentham Science Publishers

Access to resources Recommend Favorite

Cognitive Behavioral Therapy in Prodromal Psychosis

By  

Current Pharmaceutical Design, Vol. 18, Iss. 4, 2012-02 ,pp. : 558-565

Bentham Science Publishers

Access to resources Recommend Favorite

Cannabis Use in Patients at Clinical High Risk of Psychosis: Impact on Prodromal Symptoms and Transition to Psychosis

By  

Current Pharmaceutical Design, Vol. 18, Iss. 32, 2012-11 ,pp. : 5036-5044

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial [Prodromal Psychosis: Diagnosis and Treatment (Executive Guest Editor: Paolo Fusar-Poli)]

By  

Current Pharmaceutical Design, Vol. 18, Iss. 4, 2012-02 ,pp. : 337-337

Bentham Science Publishers

Access to resources Recommend Favorite